Table I.
Serial No. (Patient No.) | No. of follow ups | B19 IgM antibodies | IgG antibodies | PCR (VP1-VP2 common region) | Nested- PCR VP1 unique region |
---|---|---|---|---|---|
1. | I | – | – | – | – |
(Patient no. 2) | II | + | + | + | + |
III | – | + | – | – | |
IV | – | + | – | – | |
V | – | _ | – | – | |
2. | I | ++ | – | – | – |
(Patient no. 12) | II | + | ++ | – | – |
III | – | + | – | – | |
3. | I | – | – | – | – |
(Patient no. 3)# | II | + | – | + | + |
III | – | + | – | – | |
4. | I | + | – | – | – |
(Patient no. 15)* | II | ++ | – | – | – |
III | – | + | – | – | |
5. | I | – | – | – | – |
(Patient no. 17)# | II | ++ | ++ | – | – |
III | – | – | – | – | |
6. (Patient no. 27) | I | – | – | – | – |
II | + | – | – | – | |
III | – | + | – | – |
S.No. 1-5 had ALL, S.No. 6 had NHL;
Giant pronormoblast (Lantern cell) Seen;
atypical maculopapular rash over both lower limbs